title: Gabapentin as add-on treatment for somatoform disorder:  a case report.
abstract: Somatoform disorder is a relatively common and severe disorder for which pharmacotherapy has been minimally studied. We report a case of 30-year-old woman with treatment-resistant somatoform disorder that was successfully treated with add-on treatment of gabapentin. Our result showed that gabapentin 1800 mg/day could be tried in case of treatment-resistant somatoform disorder as an add-on strategy. However, controlled trials are needed to investigate the effectiveness of gabapentin in the management of this condition.
authors.affiliation: Department of Neuroscience, Institute of Psychiatry, Catholic University of Rome, Rome, Italy. ricguglielmo@gmail.com
authors.forename: Riccardo
authors.initials: R
authors.lastname: Guglielmo
authors.forename: Giovanni
authors.initials: G
authors.lastname: Martinotti
authors.forename: Luigi
authors.initials: L
authors.lastname: Janiri
mesh_terms: D000328:Adult; D000588:Amines / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use; D018692:Antimanic Agents / Q000627:therapeutic use; D003509:Cyclohexanecarboxylic Acids / Q000627:therapeutic use*; D005260:Female; D000077206:Gabapentin; D006801:Humans; D011569:Psychiatric Status Rating Scales; D013001:Somatoform Disorders / Q000188:drug therapy*; D005680:gamma-Aminobutyric Acid / Q000627:therapeutic use*
chemical_list: D000588:Amines; D000927:Anticonvulsants; D018692:Antimanic Agents; D003509:Cyclohexanecarboxylic Acids; D005680:gamma-Aminobutyric Acid; D000077206:Gabapentin